COVID-19: Vaccine Distribution, Supply and Allocations

$230.00

James K. Farr (Editor)

Series: New Developments in Medical Research

BISAC: MED022090

Multiple federal agencies, through Operation Warp Speed, continue to support the development and manufacturing of vaccines and therapeutics to prevent and treat COVID-19. As of January 2021, two of the six vaccines supported by Operation Warp Speed have been authorized for emergency use, and vaccine distribution and administration have begun. Effective coordination and communication among federal agencies, commercial partners, jurisdictions, and providers is critical to successfully deploying COVID-19 vaccines and managing public expectations, especially because the initial supply of vaccine has been limited.

Clear

Details

Preface

Chapter 1. COVID-19: Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal Attention
(United States Government Accountability Office)

Chapter 2. COVID-19 Vaccine Doses: Selected Data Sources on Allocation, Distribution, and Administration
(Ada S. Cornell and Angela Napili)

Chapter 3. Operation Warp Speed Contracts for COVID-19 Vaccines and Ancillary Vaccination Materials
(Simi V. Siddalingaiah)

Index

Additional information

Binding

,